SCHEMBL21482699

SCHEMBL21482699

CC(C)C(CS(=O)(=O)c1nnnn1-c1ccccc1)c1ccccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 15/20 0.51
▸ MAPT P10636 8/20 0.51
▸ LMNA P02545 7/20 0.47
▸ HTT P42858 6/20 0.47
▸ TP53 P04637 5/20 0.47
▸ NPSR1 Q6W5P4 4/20 0.47
▸ HPGD P15428 4/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ S1PR4 O95977 1/20 0.39
▸ S1PR1 P21453 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ TSHR P16473 3/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ GFER P55789 1/20 0.36
▸ ALOX15 P16050 1/20 0.35
▸ PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17255793 0.88 ALDH1A1 (0.53) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL30882163 0.88 ALDH1A1 (0.53) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL17255796 0.88 ALDH1A1 (0.53) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL30882162 0.88 ALDH1A1 (0.53) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL30743819 0.88 ALDH1A1 (0.53) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL21482468 0.79 ALDH1A1 (0.51) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL12398243 0.78 ALDH1A1 (0.58) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL21464203 0.78 ALDH1A1 (0.52) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL31208465 0.78 ALDH1A1 (0.52) ALDH1A1MAPTLMNAHTTTP53
SCHEMBL21482460 0.77 ALDH1A1 (0.49) ALDH1A1MAPTLMNAHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462594-A Pradienolide compound and application thereof 卫材R&D管理有限公司 2025-02-18 — — CN disclosed
US-20240368140-A1 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-11-07 — — US disclosed
US-11926619-B2 Certain pladienolide compounds and methods of use EISAI R & D MANAGEMENT CO., LTD. (JP) 2024-03-12 — — US disclosed
CN-113166091-A Pladienolide compounds and uses thereof 卫材R&D管理有限公司 2021-07-23 — — CN disclosed
US-20210163456-A1 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-06-03 — — US disclosed
US-20210163456-A1 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-06-03 — — US disclosed
WO-2019199667-A2 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE KEANEY GREGG F (US) 2019-10-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163456-A1 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE PLAAT5, PLAAT3, PLAAT4 ALDH1A1 3225/4885MAPT 4316/4885LMNA 806/4885
US-20240368140-A1 CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE PLAAT5, PLAAT3, PLAAT4 ALDH1A1 3225/4885MAPT 4316/4885LMNA 806/4885
US-11926619-B2 Certain pladienolide compounds and methods of use PLAAT5, PLAAT3, PLAAT4 ALDH1A1 3225/4885MAPT 4316/4885LMNA 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback